| Dr Randall Jiro Nitta, MD | |
|
98-1247 Kaahumanu St Ste 306, Aiea, HI 96701-5301 | |
| (808) 260-4404 | |
| (808) 484-2864 |
| Full Name | Dr Randall Jiro Nitta |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 98-1247 Kaahumanu St Ste 306, Aiea, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588757066 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD9319 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health Care | Honolulu, HI | Home health agency |
| Pali Momi Medical Center | Aiea, HI | Hospital |
| Entity Name | Sutter Health Pacific |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477519908 PECOS PAC ID: 1557251824 Enrollment ID: O20040318001619 |
News Archive
Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantly fewer injection site reactions (ISRs) compared to patients on Betaferon- (interferon beta-1b), Copaxone- (glatiramer Acetate) or Rebif - (interferon beta-1a).
Neuren Pharmaceuticals has announced that its patent application entitled "GPE Analogs and Peptidomimetics" (PCT/US02/16361) has been issued in the United States (US Patent No: 7,041,314) on 9 May 2006.
HemoShear, LLC, is pleased to announce that it was awarded a Phase 1 Small Business Innovation Research grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.
Medications commonly prescribed to treat high blood pressure may also reduce patients' colorectal cancer risk, according to new research published today in Hypertension, an American Heart Association journal.
› Verified 9 days ago
| Entity Name | Randall J Nitta Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134553597 PECOS PAC ID: 7719116383 Enrollment ID: O20140130000296 |
News Archive
Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantly fewer injection site reactions (ISRs) compared to patients on Betaferon- (interferon beta-1b), Copaxone- (glatiramer Acetate) or Rebif - (interferon beta-1a).
Neuren Pharmaceuticals has announced that its patent application entitled "GPE Analogs and Peptidomimetics" (PCT/US02/16361) has been issued in the United States (US Patent No: 7,041,314) on 9 May 2006.
HemoShear, LLC, is pleased to announce that it was awarded a Phase 1 Small Business Innovation Research grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.
Medications commonly prescribed to treat high blood pressure may also reduce patients' colorectal cancer risk, according to new research published today in Hypertension, an American Heart Association journal.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Randall Jiro Nitta, MD 98-1247 Kaahumanu St Ste 306, Aiea, HI 96701-5301 Ph: (808) 260-4404 | Dr Randall Jiro Nitta, MD 98-1247 Kaahumanu St Ste 306, Aiea, HI 96701-5301 Ph: (808) 260-4404 |
News Archive
Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantly fewer injection site reactions (ISRs) compared to patients on Betaferon- (interferon beta-1b), Copaxone- (glatiramer Acetate) or Rebif - (interferon beta-1a).
Neuren Pharmaceuticals has announced that its patent application entitled "GPE Analogs and Peptidomimetics" (PCT/US02/16361) has been issued in the United States (US Patent No: 7,041,314) on 9 May 2006.
HemoShear, LLC, is pleased to announce that it was awarded a Phase 1 Small Business Innovation Research grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.
Medications commonly prescribed to treat high blood pressure may also reduce patients' colorectal cancer risk, according to new research published today in Hypertension, an American Heart Association journal.
› Verified 9 days ago
Richard Kline, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 808-486-6000 | |
Kellie Wo, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 3030, Aiea, HI 96701 Phone: 808-627-3254 | |
Samuel Andrade, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 3030, Aiea, HI 96701 Phone: 808-627-3200 | |
David Lyn Swanson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 808-486-6000 | |
Dr. Agnes Serranilla-sonido, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 3030, Aiea, HI 96701 Phone: 808-627-3254 Fax: 808-627-3265 | |
Nataliya Panova, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 3030, Aiea, HI 96701 Phone: 808-627-3254 | |
Melissa Malia Narvaez Gozun, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 3030, Aiea, HI 96701 Phone: 808-627-3254 |